vs
IRIDEX CORP（IRIX）与UNIVERSAL HEALTH REALTY INCOME TRUST（UHT）财务数据对比。点击上方公司名可切换其他公司
UNIVERSAL HEALTH REALTY INCOME TRUST的季度营收约是IRIDEX CORP的1.7倍（$24.5M vs $14.7M），UNIVERSAL HEALTH REALTY INCOME TRUST同比增速更快（-0.7% vs -69.7%），过去两年IRIDEX CORP的营收复合增速更高（11.9% vs -1.3%）
IRIDEX Corporation是一家全球性医疗科技企业，主要研发、生产和销售面向眼科及医疗美容领域的激光类医疗设备，产品供应至北美、欧洲、亚太等地区的医疗机构与诊所，为眼部疾病治疗和医美项目提供微创解决方案。
环球健康服务公司（UHS）是一家总部位于宾夕法尼亚州普鲁士国王市的美国医疗服务企业，位列财富500强，主营医院运营及各类医疗保健服务。该公司2024年公布的总营收达158亿美元。
IRIX vs UHT — 直观对比
营收规模更大
UHT
是对方的1.7倍
$14.7M
营收增速更快
UHT
高出69.1%
-69.7%
两年增速更快
IRIX
近两年复合增速
-1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.7M | $24.5M |
| 净利润 | — | $4.3M |
| 毛利率 | 37.2% | — |
| 营业利润率 | — | 34.7% |
| 净利率 | — | 17.7% |
| 营收同比 | -69.7% | -0.7% |
| 净利润同比 | — | -7.2% |
| 每股收益（稀释后） | — | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRIXUHT
| Q4 25 | $14.7M | $24.5M | ||
| Q3 25 | $12.5M | $25.3M | ||
| Q2 25 | $13.6M | $24.9M | ||
| Q1 25 | $11.9M | $24.5M | ||
| Q4 24 | $12.7M | $24.6M | ||
| Q3 24 | $11.6M | $24.5M | ||
| Q2 24 | $12.6M | $24.7M | ||
| Q1 24 | $11.8M | $25.1M |
净利润IRIXUHT
| Q4 25 | — | $4.3M | ||
| Q3 25 | $-1.6M | $4.0M | ||
| Q2 25 | $-994.0K | $4.5M | ||
| Q1 25 | $-1.7M | $4.8M | ||
| Q4 24 | $-834.0K | $4.7M | ||
| Q3 24 | $-1.9M | $4.0M | ||
| Q2 24 | $-2.7M | $5.3M | ||
| Q1 24 | $-3.5M | $5.3M |
毛利率IRIXUHT
| Q4 25 | 37.2% | — | ||
| Q3 25 | 32.1% | — | ||
| Q2 25 | 34.5% | — | ||
| Q1 25 | 42.5% | — | ||
| Q4 24 | 44.0% | — | ||
| Q3 24 | 37.3% | — | ||
| Q2 24 | 40.7% | — | ||
| Q1 24 | 37.9% | — |
营业利润率IRIXUHT
| Q4 25 | — | 34.7% | ||
| Q3 25 | -11.3% | 33.2% | ||
| Q2 25 | -6.9% | 35.6% | ||
| Q1 25 | -1.7% | 36.8% | ||
| Q4 24 | -3.9% | 37.6% | ||
| Q3 24 | -16.1% | 34.7% | ||
| Q2 24 | -20.9% | 38.7% | ||
| Q1 24 | -28.0% | 37.6% |
净利率IRIXUHT
| Q4 25 | — | 17.7% | ||
| Q3 25 | -12.6% | 15.9% | ||
| Q2 25 | -7.3% | 18.1% | ||
| Q1 25 | -14.2% | 19.5% | ||
| Q4 24 | -6.6% | 18.9% | ||
| Q3 24 | -16.7% | 16.3% | ||
| Q2 24 | -21.2% | 21.3% | ||
| Q1 24 | -29.5% | 21.1% |
每股收益（稀释后）IRIXUHT
| Q4 25 | — | $0.32 | ||
| Q3 25 | $-0.09 | $0.29 | ||
| Q2 25 | $-0.06 | $0.32 | ||
| Q1 25 | $-0.10 | $0.34 | ||
| Q4 24 | $-0.05 | $0.34 | ||
| Q3 24 | $-0.12 | $0.29 | ||
| Q2 24 | $-0.16 | $0.38 | ||
| Q1 24 | $-0.21 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.0M | $6.7M |
| 总债务越低越好 | — | $374.8M |
| 股东权益账面价值 | — | $152.4M |
| 总资产 | $29.2M | $564.9M |
| 负债/权益比越低杠杆越低 | — | 2.46× |
8季度趋势，按日历期对齐
现金及短期投资IRIXUHT
| Q4 25 | $6.0M | $6.7M | ||
| Q3 25 | $5.6M | $6.9M | ||
| Q2 25 | $6.8M | $6.6M | ||
| Q1 25 | $7.2M | $7.0M | ||
| Q4 24 | $2.4M | $7.1M | ||
| Q3 24 | $3.9M | $6.4M | ||
| Q2 24 | $4.1M | $5.6M | ||
| Q1 24 | $5.4M | $7.7M |
总债务IRIXUHT
| Q4 25 | — | $374.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.0M | $368.4M | ||
| Q3 24 | $1.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IRIXUHT
| Q4 25 | — | $152.4M | ||
| Q3 25 | $4.7M | $158.6M | ||
| Q2 25 | $6.1M | $165.2M | ||
| Q1 25 | $852.0K | $172.2M | ||
| Q4 24 | $2.1M | $179.5M | ||
| Q3 24 | $2.6M | $181.6M | ||
| Q2 24 | $4.2M | $190.7M | ||
| Q1 24 | $6.5M | $196.5M |
总资产IRIXUHT
| Q4 25 | $29.2M | $564.9M | ||
| Q3 25 | $28.4M | $568.0M | ||
| Q2 25 | $31.6M | $573.0M | ||
| Q1 25 | $34.2M | $573.5M | ||
| Q4 24 | $29.1M | $580.9M | ||
| Q3 24 | $30.2M | $584.3M | ||
| Q2 24 | $31.2M | $586.6M | ||
| Q1 24 | $34.1M | $596.2M |
负债/权益比IRIXUHT
| Q4 25 | — | 2.46× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.48× | 2.05× | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $49.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 11.35× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流IRIXUHT
| Q4 25 | — | $49.1M | ||
| Q3 25 | $-1.2M | $10.2M | ||
| Q2 25 | $-397.0K | $13.7M | ||
| Q1 25 | $-1.1M | $11.6M | ||
| Q4 24 | $-1.2M | $46.9M | ||
| Q3 24 | $-3.1M | $9.9M | ||
| Q2 24 | $-1.3M | $12.1M | ||
| Q1 24 | $-1.6M | $11.7M |
自由现金流IRIXUHT
| Q4 25 | — | — | ||
| Q3 25 | $-1.2M | — | ||
| Q2 25 | $-410.0K | — | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-3.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-1.7M | — |
自由现金流率IRIXUHT
| Q4 25 | — | — | ||
| Q3 25 | -9.4% | — | ||
| Q2 25 | -3.0% | — | ||
| Q1 25 | -9.8% | — | ||
| Q4 24 | -9.8% | — | ||
| Q3 24 | -26.5% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -14.0% | — |
资本支出强度IRIXUHT
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率IRIXUHT
| Q4 25 | — | 11.35× | ||
| Q3 25 | — | 2.54× | ||
| Q2 25 | — | 3.05× | ||
| Q1 25 | — | 2.43× | ||
| Q4 24 | — | 10.06× | ||
| Q3 24 | — | 2.48× | ||
| Q2 24 | — | 2.30× | ||
| Q1 24 | — | 2.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRIX
暂无分部数据
UHT
| Reportable Segment Aggregation Before Other Operating Segment | $23.1M | 94% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $2.3M | 9% |
